BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 23, 2003
View Archived Issues
New phase IIIb studies evaluate Estorra in various patient populations
Read More
Capital raised to fund Tranzyme/Neokimia merger
Read More
TGN-167 successfully completes phase I trial
Read More
Vicuron seeks European approval for anidulafungin
Read More
ViroPharma discovers compounds active against New World arenaviruses
Read More
Canadian Tectin trial in severe nonmalignant chronic pain cleared to begin
Read More
Highlights from the 2003 AACR-NCI-EORTC International Conference available on the LifeSci Channel
Read More
Alexion and XOMA collaborate on c-MPL agonist antibody development
Read More
ArQule achieves 2003 Pfizer collaboration goals
Read More
Array BioPharma and AstraZeneca to develop MEK program for oncology
Read More
Phase II Pentrix trial cleared to commence
Read More
Photobarr PDT recommended for approval in E.U.
Read More
Chiron grants HCV license to Boehringer Ingelheim
Read More
Lp-PLA2 targeted for coronary disease
Read More
Pyridine-based thyroid receptor modulators described by BMS
Read More
Two new series of piperidine derivatives claimed by Procter & Gamble
Read More
ICAgen describes new series of potassium channel modulators
Read More
Mitotic kinesin KSP inhibitors reported by Cytokinetics and GlaxoSmithKline
Read More
Combination of proton pump inhibitor with airway therapeutic claimed by Altana patent
Read More
Remodulin: Swiss approval, Australian approval recommendation
Read More
NDA filings cover rapid dissolve formulations of Aricept
Read More
Phase I trial of VRX-496 modified T-cells continues with third patient
Read More
COX17 as a novel target for NSCLC
Read More
Novel calpain inhibitor SNJ-1757 identified as anticataract agent with good corneal permeability
Read More
L-756867, the first inverse ghrelin agonist, has possible implications for the treatment of obesity
Read More
GlaxoSmithKline, Institut Pasteur team up to develop SARS vaccine
Read More